Cardiac Implantable Electronic Device Market Analysis-2027

1. CARDIAC IMPLANTABLE ELECTRONIC DEVICE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Cardiac Implantable Electronic Device Market - Overview Global Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 22,576.2 million in 2020 and is expected to exhibit a CAGR 7.7% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The rapidly evolving COVID-19 pandemic at global level is impacting the cardiac implantable electronic device market negatively. As the hospital outpatient-based cardiac care departments have been placed in the non-essential group by many hospitals, it has become a difficult situation for the patients with cardiac disease. Rising incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to fuel growth of the cardiac implantable electronic device market. According to WHO report, in 2015, cardiovascular diseases was the leading cause of deaths, which accounted for 17.7 million deaths, worldwide. For instance, adoption of advanced technologies in cardiac pacemakers such as pacemakers with improved battery life and MRI safe-pacemakers delay the progression of persistent atrial fibrillation (AF) in patients suffering from bradycardia. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/cardiac- implantable-electronic-device-market-3949 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION These advancements are gaining significant traction and are expected to fuel demand for cardiac rhythm management devices. For instance, in February 2017, Abbott received the U.S Food and Drug Administration (FDA) approval for its MR-conditional labeling for Assurity MRI pacemaker and the Tendril MRI pacing lead. Browse 26 Market Data Tables and 25 Figures spread through 195 Pages and in-depth TOC on Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027" Major players are adopting strategies such as mergers and acquisitions to expand their product portfolio. For instance, in November 2017, LivaNova PLC and MicroPort Scientific Corporation entered into a binding Letter of Intent (LOI) to sell LivaNova’s Cardiac Rhythm Management (CRM) business franchise to MicroPort for US$ 190 million. The LivaNova PLC Company’s CRM product portfolio includes pacemakers, high-voltage defibrillators, and cardiac resynchronization therapy devices. Furthermore, technological advancements in cardiac management devices is a major factor driving growth of the market. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3949 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Cardiac Implantable Electronic Device Market: The cardiac implantable electronic device market is expected to exhibit a CAGR of 7.7% over the forecast period (2020-2027), owing to rising incidence of cardiac disorders Among type, the implantable pacemakers segment is expected to hold major revenue share in 2027. The introduction of advanced technologies such as wireless and automated pacemaker and monitoring pacemakers are gaining significant traction among healthcare providers. For instance, in 2016, Biotronik launched CardioMessenger Smart, a portable monitoring device, in the U.S. This system is about the size of a modern smartphone used to keep pacemaker, implantable cardioverter defibrillator (ICD), and insertable cardiac monitor (ICM) patients connected to their physician remotely. This CardioMessenger Smart helps to ensure patient compliance and consistent transmission of data necessary for physicians to identify and prevent potential cardiac events. Major players operating in the cardiac implantable electronic device market include Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3949 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved